Please login to the form below

Not currently logged in

anal cancer

This page shows the latest anal cancer news and features for those working in and with pharma, biotech and healthcare.

Gardasil cleared for anal cancer prevention in EU

Gardasil cleared for anal cancer prevention in EU

It is also approved to prevent genital warts. Specifically, the EC has cleared Gardasil to prevent anal cancer and anal precancerous lesions – or anal intraepithelial neoplasia (AIN) - caused by HPV, recognising ... Cervarix has also been shown in

Latest news

  • New FDA approval for Merck's Gardasil

    Merck's HPV vaccine, Gardasil, has received approval from the US Food and Drug Administration for the prevention of anal cancer due to HPV. ... A panel of FDA advisors had previously recommended the agency approve Gardasil for the indication of

  • FDA advisors support anal cancer vaccine

    Outside advisors to the US Food and Drug Administration have recommended the approval of Merck's Gardasil in preventing anal cancer. ... preventing anal cancer, which is caused by human papillomavirus (HPV) in approximately 90 per cent of cases. .

  • Gardasil effective against anal cancer

    Merck's Gardasil has shown to be effective in preventing HPV-related anal cancer, according to results from a phase III trial. ... No cases of anal cancer were seen in either the placebo or vaccine group.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    Practitioners were concerned that a hasty introduction of the vaccine would lead to lower participation rates in cervical cancer screening programmes using the pap smear test. ... For example, the remarkable silence around the fact that some strains of

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....